About Us
Company Profile
Management Team
Business Model
Milestones
Contact Us
Product & Pipeline
ONIVYDE®
PEP07 (CHK1 inhibitor)
PEP08 (PRMT5:MTA inhibitor)
Investors
Fundamentals
Events & Presentations
Financial Reports
Shareholders' Meeting
News
Corporate Governance
Overview
Board of Directors
Functional Committees
Communication with Independent Directors
Major Internal Policies
Risk Management
Cyber Security
Intellectual Property Management
Sustainability
Corporate Social Responsibility
Ethical Management
Stakeholder Communication
Human Rights
Health & Safety
Careers
EN
Chinese
Home
About Us
Company Profile
Management Team
Business Model
Milestones
Contact Us
Product & Pipeline
ONIVYDE®
PEP07 (CHK1 inhibitor)
PEP08 (PRMT5:MTA inhibitor)
Investors
Fundamentals
Events & Presentations
Financial Reports
Shareholders' Meeting
News
Corporate Governance
Overview
Board of Directors
Functional Committees
Communication with Independent Directors
Major Internal Policies
Risk Management
Cyber Security
Intellectual Property Management
Sustainability
Corporate Social Responsibility
Ethical Management
Stakeholder Communication
Human Rights
Health & Safety
Careers
Language
EN
Chinese
Financial Reports
Homepage
Investors
Financial Reports
2025
2024
2023
2022
2021
Monthly Revenue
1-12Month
Download
Quarterly Report
1Q24
Download
2Q24
Download
3Q24
Download
4Q24
Download
